drugset / Trial / NCT06204679
Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir
RandomizedCrossoverOpen-labelTreatment
Summary
This study will assess comparative bioavailability and effect of food on a prototype fixed-dose combination (FDC) of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in healthy subjects
Timeline
- Start
- 2023-12-14
- Primary completion
- 2024-08-25
- Completion
- 2024-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bemnifosbuvir | Other / unclassified | — | — |
| Subject | Ruzasvir | Other / unclassified | — | — |
Indications
No indication recorded.